Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 242

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases

Open access
Chen, Xilin, Han, Jianfeng, Chu, Jianhong, Zhang, Lingling, Zhang, Jianying, Chen, Charlie, Chen, Luxi, Wang, Youwei, Wang, Hongwei, Yi, Long, Elder, J. Bradley, Wang, Qi-En, He, Xiaoming, Kaur, Balveen, Chiocca, E. Antonio, Yu, Jianhua·2016·Oncotarget

Abstract

// Xilin Chen 1, 2, * , Jianfeng Han 3, * , Jianhong Chu 3, 4, * , Lingling Zhang 3, * , Jianying Zhang 5 , Charlie Chen 3 , Luxi Chen 3 , Youwei Wang 3 , Hongwei Wang 3 , Long Yi 3 , J. Bradley Elder 3, 8 , Qi-En Wang 6 , Xiaoming He 7 , Balveen Kaur 3, 8 , E. Antonio Chiocca 9 , Jianhua Yu 1, 3, 10 1 Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA 2 Lymphoma/Head and Neck Oncology Department, 307 Hospital, Beijing 100071, China 3 The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA 4 Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215000, China 5 Center for Biostatistics, The Ohio State University, Columbus, Ohio 43210, USA 6 Department of Radiology, The Ohio State University, Columbus, Ohio 43210, USA 7 Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio 43210, USA 8 Department of Neurological Surgery, The Ohio State University, Columbus, Ohio 43210, USA 9 Department of Neurosurgery, Brigham and Women’s Hospital and Harvey Cushing Neuro-oncology Laboratories, Harvard Medical School, Boston, Massachusetts 02115, USA 10 The James Cancer Hospital, Columbus, OH 43210, USA * These authors have contributed equally to this work Correspondence to: Jianhua Yu, e-mail: jianhua.yu@osumc.edu Keywords: breast cancer brain metastases, chimeric antigen receptor, natural killer cells, EGFR, oncolytic virus Received: October 13, 2015 Accepted: March 16, 2016 Published: April 01, 2016 ABSTRACT Breast cancer brain metastases (BCBMs) are common in patients with metastatic breast cancer and indicate a poor prognosis. These tumors are especially resistant to currently available treatments due to multiple factors. However, the combination of chimeric antigen receptor (CAR)-modified immune cells and oncolytic herpes simplex virus (oHSV) has not yet been explored in this context. In this study, NK-92 cells and primary NK cells were engineered to express the second generation of EGFR-CAR. The efficacies of anti-BCBMs of EGFR-CAR NK cells, oHSV-1, and their combination were tested in vitro and in a breast cancer intracranial mouse model. In vitro , compared with mock-transduced NK-92 cells or primary NK cells, EGFR-CAR-engineered NK-92 cells and primary NK cells displayed enhanced cytotoxicity and IFN-γ production when co-cultured with breast cancer cell lines MDA-MB-231, MDA-MB-468, and MCF-7. oHSV-1 alone was also capable of lysing and destroying these cells. However, a higher cytolytic effect of EGFR-CAR NK-92 cells was observed when combined with oHSV-1 compared to the monotherapies. In the mice intracranially pre-inoculated with EGFR-expressing MDA-MB-231 cells, intratumoral administration of either EGFR-CAR-transduced NK-92 cells or oHSV-1 mitigated tumor growth. Notably, the combination of EGFR-CAR NK-92 cells with oHSV-1 resulted in more efficient killing of MDA-MB-231 tumor cells and significantly longer survival of tumor-bearing mice when compared to monotherapies. These results demonstrate that regional administration of EGFR-CAR NK-92 cells combined with oHSV-1 therapy is a potentially promising strategy to treat BCBMs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.8526

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 242

Metadata

Authors
Chen, X., Han, J., Chu, J., Zhang, L., Zhang, J., Chen, C., Chen, L., Wang, Y., Wang, H., Yi, L., Elder, J. B., Wang, Q.-E., He, X., Kaur, B., Chiocca, E. A., & Yu, J.
Venue
Oncotarget
Published
2016-04-01
Volume
7
Issue
19
Pages
27764-27777
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2331962566
Cited by
242
References
3
FWCI
11.50
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases. https://app.cochat.ai/papers/10.18632/oncotarget.8526
The paper
Chen, X., Han, J., Chu, J., Zhang, L., Zhang, J., Chen, C., Chen, L., Wang, Y., Wang, H., Yi, L., Elder, J. B., Wang, Q.-E., He, X., Kaur, B., Chiocca, E. A., & Yu, J. (2016). A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases. Oncotarget. https://doi.org/10.18632/oncotarget.8526

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.